Global pharmaceutical manufacturer AstraZeneca has admitted that its COVID-19 vaccine, developed by researchers from the Oxford University, can cause a rare side effect of blood clotting and low platelet count after immunisation. In India, the same vaccine, called Covishield and manufactured by the Pune-based Serum Institute, has been administered through 175 crore doses. Understandably, this raises questions as to the safety of the jab all of us took. The company made this admission of a side... Read this story